Instead, Du et al. demonstrated the binding of CRPV E6 (LE6 = long E6 and SE6 = short E6) to another tumor suppressor, hDlg/SAP97, which could explain its oncogenic potential analogous to p53 inhibition [49]. Here, DLG1 is linked to neoplasm.